secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tevogen Bio Holdings Inc. (TVGN)
CIK:        0001860871
Form:       8-K
Filed at:   2025-01-28T23:59:59+00:00
Accession:  0001493152-25-004002
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tevogen Bio receives $2M grant from KRHP LLC; up to $10M non-dilutive funding
-----------------------------------------------------------------------------

- Initial $2M grant from KRHP LLC; additional $8M contingent on KRHP's review of activities.
- Funding is non-dilutive and will support development of off-the-shelf T cell therapies for cancers and viral infections.
- Tevogen may also use grant to expand AI efforts (Tevogen.AI) in partnership with Microsoft.
- KRHP LLC is affiliated with spouse of Dr. Manmohan Patel, an existing >5% beneficial owner of TVGN common stock.
- Grant is in addition to previously announced $36M loan agreement from Q2 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860871/000149315225004002/0001493152-25-004002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860871/000149315225004002/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-004002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer